Aminoglutethimide-induced hematologic toxicity: worldwide experience
- PMID: 4028032
Aminoglutethimide-induced hematologic toxicity: worldwide experience
Abstract
Marked leukopenia and/or thrombocytopenia occurred in 12 of 1333 patients treated with aminoglutethimide (0.9% incidence). Depression of blood cell counts was evident within 7 weeks of starting treatment. No delayed toxicity was encountered. Blood cell counts recovered promptly upon cessation of aminoglutethimide in all but one patient, who died from septicemia and marrow aplasia.
MeSH terms
Substances
LinkOut - more resources
Medical